Julie Parsonnet

Clinical Focus

• Infectious Disease
• Infectious Diseases

Administrative Appointments

• Sr. Associate Dean for Medical Education, Stanford University , (2001– 2006 )
• Chief, Infectious Diseases and Geographic Medicine, Stanford, Department of Medicine , (1998– 2001 )

Honors and Awards

• Henry J. Kaiser Family Foundation Award for Excellence in Preclinical Teaching, Stanford University (2002)
• Henry J. Kaiser Award for Innovation in Medical Education, Stanford University (2004)
• Member, American Society for Clinical Investigation (1998)
• Best Doctors in the U.S, Best Doctors (2001, 2005. 2007)

Professional Education

• Massachusetts General Hospital (1989) MA
• Massachusetts General Hospital (1987) MA
• Massachusetts General Hospital (1986) MA
• Massachusetts General Hospital (1984) MA
• Board Certification: Infectious Disease, American Board of Internal Medicine (1988)
• Board Certification: Internal Medicine, American Board of Internal Medicine (1986)
• Cornell University Medical College (1983) NY
• M.D., Cornell Medicine (1983)
• A.B., Harvard History and Science (1975)

Postdoctoral Advisees

• Alicia Chang, Gina Suh

Graduate & Fellowship Program Affiliations

• Epidemiology
• Health Research and Policy
• Medicine

Community & International Work

• Forest Conversion and the Changing Epidemiological Environment in West Kalimantan, Borneo More »
• H. pylori and tuberculosis, Gambia More »
• Immunoepidemiology of infectious diseases in immigrants, Santa Clara County More »

Web Site Links

• Parsonnet lab

Research Interests

I am interested in the long-term consequences of chronic interactions between the human host and the microbial world. Recently, we have focused most heavily on Helicobacter pylori, tuberculosis and helminth infections. I also remain strongly interested in diarrheal diseases, particularly in the developing world, and in sanitation and hygiene.

Clinical Trials

• Clinical Experiment of Helicobacter pylori Transmission No longer recruiting
• Immunobiology of Diabetes and Tuberculosis No longer recruiting

Publications

• Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. Rupnow MF,  Chang AH, Shachter RD, Owens DK, Parsonnet J.  J Infect Dis.  2009; 200 (8): 1311-7
• Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Chiu CY,  Greninger AL, Kanada K, Kwok T, Fischer KF, Runckel C, Louie JK, Glaser CA, Yagi S, Schnurr DP, Haggerty TD, Parsonnet J, Ganem D, DeRisi JL.  Proc Natl Acad Sci U S A.  2008; 105 (37): 14124-9
• Gastroenteritis and transmission of Helicobacter pylori infection in households. Perry S,  de la Luz Sanchez M, Yang S, Haggerty TD, Hurst P, Perez-Perez G, Parsonnet J.  Emerg Infect Dis.  2006; 12 (11): 1701-8
• Fecal and oral shedding of Helicobacter pylori from healthy infected adults. Parsonnet J,  Shmuely H, Haggerty T.  JAMA.  1999; 282 (23): 2240-5
• Helicobacter pylori infection and gastric lymphoma. Parsonnet J,  Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD.  N Engl J Med.  1994; 330 (18): 1267-71
• Helicobacter pylori infection and the risk of gastric carcinoma. Parsonnet J,  Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK.  N Engl J Med.  1991; 325 (16): 1127-31
• Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract. de Martel C,  Plummer M, Parsonnet J, van Doorn LJ, Franceschi S.  Br J Cancer.  2009; 100 (1): 194-9
• Helicobacter pylori and gastric adenocarcinoma. Herrera V,  Parsonnet J.  Clin Microbiol Infect.  2009; 15 (11): 971-6
• Helicobacter pylori infection and development of pancreatic cancer. de Martel C,  Llosa AE, Friedman GD, Friedmana GD, Vogelman JH, Orentreich N, Stolzenberg-Solomon RZ, Parsonnet J.  Cancer Epidemiol Biomarkers Prev.  2008; 17 (5): 1188-94
• Reproducibility of QuantiFERON-TB gold in-tube assay. Perry S,  Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J.  Clin Vaccine Immunol.  2008; 15 (3): 425-32
• Estimating disease prevalence using census data. Choy M,  Switzer P, De Martel C, Parsonnet J.  Epidemiol Infect.  2008; 136 (9): 1253-60
• Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. de Martel C,  Haggerty TD, Corley DA, Vogelman JH, Orentreich N, Parsonnet J.  Am J Gastroenterol.  2007; 102 (6): 1166-72
• Cerebral myiasis associated with angiosarcoma of the scalp: case report. Cheshier SH,  Bababeygy SR, Higgins D, Parsonnet J, Huhn SL.  Neurosurgery.  2007; 61 (1): E167; discussion E167
• Validation of the blood quininium resin test for assessing gastric hypochlorhydria. De Martel C,  Ratanasopa S, Passaro D, Parsonnet J.  Dig Dis Sci.  2006; 51 (1): 84-8
• Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy. Tsai CJ,  Herrera-Goepfert R, Tibshirani RJ, Yang S, Mohar A, Guarner J, Parsonnet J.  Cancer Epidemiol Biomarkers Prev.  2006; 15 (2): 272-80
• Investigation of mediastinitis due to coagulase-negative staphylococci after cardiothoracic surgery. Van Kerkhove MD,  Parsonnet J, Weingart M, Tompkins LS.  Infect Control Hosp Epidemiol.  2006; 27 (3): 305-7
• Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. de Martel C,  Parsonnet J.  Dig Dis Sci.  2006; 51 (12): 2292-301
• Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral-oral transmission. Solnick JV,  Fong J, Hansen LM, Chang K, Canfield DR, Parsonnet J.  J Clin Microbiol.  2006; 44 (10): 3799-803
• Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Lentine KL,  Parsonnet J, Taylor I, Wrone EM, Lafayette RA.  Clin Exp Nephrol.  2006; 10 (1): 55-62
• Concordance of Helicobacter pylori infection among children in extended-family homes. Garg PK,  Perry S, Sanchez L, Parsonnet J.  Epidemiol Infect.  2006; 134 (3): 450-9
• Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Tsai CJ,  Perry S, Sanchez L, Parsonnet J.  Am J Epidemiol.  2005; 162 (4): 351-7
• Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali: a control trial with systematic allocation of households. Rhee M,  Sissoko M, Perry S, McFarland W, Parsonnet J, Doumbo O.  Malar J.  2005; 4 35
• Cell proliferation and inflammation on biopsy samples with multifocal atrophic gastritis before and 1 year after Helicobacter pylori eradication. Guarner J,  Bartlett J, Seitz R, Whistler T, Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Parsonnet J.  Arch Pathol Lab Med.  2005; 129 (11): 1451-6
• Clinician-discoverers--Marshall, Warren, and H. pylori. Parsonnet J,  N Engl J Med.  2005; 353 (23): 2421-3
• Commentary: H. pylori infection in early life and the problem of imperfect tests. Perry S,  Parsonnet J.  Int J Epidemiol.  2005; 34 (6): 1356-8
• QuantiFERON-TB predicts tuberculin skin test boosting in U.S. foreign-born. Nguyen M,  Perry S, Parsonnet J.  Int J Tuberc Lung Dis.  2005; 9 (9): 985-91
• Risk of intestinal helminth and protozoan infection in a refugee population. Garg PK,  Perry S, Dorn M, Hardcastle L, Parsonnet J.  Am J Trop Med Hyg.  2005; 73 (2): 386-91
• Household transmission of gastroenteritis. Perry S,  de la Luz Sanchez M, Hurst PK, Parsonnet J.  Emerg Infect Dis.  2005; 11 (7): 1093-6
• Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. de Martel C,  Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, Corley DA, Parsonnet J.  J Infect Dis.  2005; 191 (5): 761-7
• Significance of transiently positive enzyme-linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children. Haggerty TD,  Perry S, Sanchez L, Perez-Perez G, Parsonnet J.  J Clin Microbiol.  2005; 43 (5): 2220-3
• Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Duck WM,  Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, Sulka A, Swaminathan B, Taylor T, Hoekstra M, Griffin P, Smoot D, Peek R, Metz DC, Bloom PB, Goldschmidt S, Parsonnet J, Triadafilopoulos G, Perez-Perez GI, Vakil N, Ernst P, Czinn S, Dunne D, Gold BD.  Emerg Infect Dis.  2004; 10 (6): 1088-94
• Helicobacter pylori and risk of gastroenteritis. Perry S,  Sanchez L, Yang S, Haggerty TD, Hurst P, Parsonnet J.  J Infect Dis.  2004; 190 (2): 303-10
• Bacterial infection and MALT lymphoma. Parsonnet J,  Isaacson PG.  N Engl J Med.  2004; 350 (3): 213-5
• Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Ley C,  Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Johnstone I, Parsonnet J.  Cancer Epidemiol Biomarkers Prev.  2004; 13 (1): 4-10
• Helicobacter pylori infection and gastric cancer--for want of more outcomes. Parsonnet J,  Forman D.  JAMA.  2004; 291 (2): 244-5
• Helicobacter pylori in cathartic stools of subjects with and without cimetidine-induced hypochlorhydria. Haggerty T,  Shmuely H, Parsonnet J.  J Med Microbiol.  2003; 52 (Pt 2): 189-91
• C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction. Witherell HL,  Smith KL, Friedman GD, Ley C, Thom DH, Orentreich N, Vogelman JH, Parsonnet J.  Ann Epidemiol.  2003; 13 (3): 170-7
• Natural acquisition of Helicobacter pylori infection in newborn rhesus macaques. Solnick JV,  Chang K, Canfield DR, Parsonnet J.  J Clin Microbiol.  2003; 41 (12): 5511-6
• Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Fowler RA,  Flavin KE, Barr J, Weinacker AB, Parsonnet J, Gould MK.  Chest.  2003; 123 (3): 835-44
• What is the Helicobacter pylori global reinfection rate? Parsonnet J,  Can J Gastroenterol.  2003; 17 Suppl B 46B-48B
• No association between Helicobacter pylori and Mycobacterium tuberculosis infections among gastrointestinal clinic attendees in Lima, Peru. Torres MA,  Passaro DJ, Watanabe J, Parsonnet J, Small P, Miyagu J, Rodriquez C, Astete M, Gilman RH.  Epidemiol Infect.  2003; 130 (1): 87-91
• Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Guarner J,  Herrera-Goepfert R, Mohar A, Smith C, Schofield A, Halperin D, Sanchez L, Parsonnet J.  Hum Pathol.  2003; 34 (1): 28-31
• [High frequency of precancerous lesions of gastric cancer associated with Helicobacter pylori and response to treatment, in Chiapas, Mexico] Mohar A,  Ley C, Guarner J, Herrera-Goepfert R, Sánchez L, Halperin D, Parsonnet J.  Gac Med Mex.  2002 Sep-Oct; 138 (5): 405-10
• Helicobacter pylori: consensus and controversy. Passaro DJ,  Chosy EJ, Parsonnet J.  Clin Infect Dis.  2002; 35 (3): 298-304
• Validation of Spanish language dyspepsia questionnaire. Goldman J,  Conrad DF, Ley C, Halperin D, de la Luz Sanchez M, Villacorta R, Parsonnet J.  Dig Dis Sci.  2002; 47 (3): 624-40
• CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Shibata A,  Parsonnet J, Longacre TA, Garcia MI, Puligandla B, Davis RE, Vogelman JH, Orentreich N, Habel LA.  Carcinogenesis.  2002; 23 (3): 419-24
• Growth slowing after acute Helicobacter pylori infection is age-dependent. Passaro DJ,  Taylor DN, Gilman RH, Cabrera L, Parsonnet J.  J Pediatr Gastroenterol Nutr.  2002; 35 (4): 522-6
• A modification of the quininium resin test for assessing gastric acidity. Passaro DJ,  Hurwitz A, Triadafilopoulos G, Parsonnet J.  Aliment Pharmacol Ther.  2002; 16 (5): 875-80
• Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. Mohar A,  Ley C, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J.  Am J Gastroenterol.  2002; 97 (10): 2530-5
• Variability of serologic testing for H. pylori using U.S. and Peruvian antigens. De Arruda SM,  Passaro DJ, Parsonnet J.  Gastroenterology.  2001; 120 (1): 325-6
• Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta). Solnick JV,  Hansen LM, Canfield DR, Parsonnet J.  Infect Immun.  2001; 69 (11): 6887-92
• Helicobacter pylori and risk for gastric adenocarcinoma. Asghar RJ,  Parsonnet J.  Semin Gastrointest Dis.  2001; 12 (3): 203-8
• Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. Passaro DJ,  Taylor DN, Meza R, Cabrera L, Gilman RH, Parsonnet J.  Pediatrics.  2001; 108 (5): E87
• Quantifying the population impact of a prophylactic Helicobacter pylori vaccine. Rupnow MF,  Shachter RD, Owens DK, Parsonnet J.  Vaccine.  2001; 20 (5-6): 879-85
• Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Liesenfeld O,  Montoya JG, Tathineni NJ, Davis M, Brown BW, Cobb KL, Parsonnet J, Remington JS.  Am J Obstet Gynecol.  2001; 184 (2): 140-5
• Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients. Guarner J,  Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, Parsonnet J.  Hum Pathol.  2001; 32 (1): 31-5
• Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Shibata A,  Longacre TA, Puligandla B, Parsonnet J, Habel LA.  Cancer Epidemiol Biomarkers Prev.  2001; 10 (1): 75-8
• Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Ley C,  Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J.  Cancer Epidemiol Biomarkers Prev.  2001; 10 (2): 107-12
• Helicobacter pylori infection and gastric cancer. Ley C,  Parsonnet J.  Gastroenterology.  2001; 120 (1): 324-5
• Is anything safe to eat? Sobel J,  Swerdlow DL, Parsonnet J.  Curr Clin Top Infect Dis.  2001; 21 114-34
• A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. Rupnow MF,  Shachter RD, Owens DK, Parsonnet J.  Emerg Infect Dis.  2000 May-Jun; 6 (3): 228-37
• When heredity is infectious. Parsonnet J,  Gastroenterology.  2000; 118 (1): 222-4
• Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology. Rupnow MF,  Owens DK, Shachter R, Parsonnet J.  Helicobacter.  1999; 4 (4): 272-80
• Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori? Harris RA,  Owens DK, Witherell H, Parsonnet J.  Helicobacter.  1999; 4 (2): 69-76
• Patterns of health seeking behavior during episodes of childhood diarrhea: a study of Tzotzil-speaking Mayans in the highlands of Chiapas, Mexico. Granich R,  Cantwell MF, Long K, Maldonado Y, Parsonnet J.  Soc Sci Med.  1999; 48 (4): 489-95
• Rhesus monkey (Macaca mulatta) model of Helicobacter pylori: noninvasive detection and derivation of specific-pathogen-free monkeys. Solnick JV,  Canfield DR, Yang S, Parsonnet J.  Lab Anim Sci.  1999; 49 (2): 197-201
• Helicobacter pylori virulence and genetic geography. Covacci A,  Telford JL, Del Giudice G, Parsonnet J, Rappuoli R.  Science.  1999; 284 (5418): 1328-33
• Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. McFarland W,  Gwanzura L, Bassett MT, Machekano R, Latif AS, Ley C, Parsonnet J, Burke RL, Katzenstein D.  J Infect Dis.  1999; 180 (5): 1459-65
• Interobserver variability in application of the revised Sydney classification for gastritis. Guarner J,  Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, Parsonnet J.  Hum Pathol.  1999; 30 (12): 1431-4
• Parsonnet J(ed),  Microbes and Malignancy: Infection as a Cause of Human Cancer.  1999; (New York): Oxford Univ. Press
• Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct. Witherell HL,  Hiatt RA, Replogle M, Parsonnet J.  Cancer Epidemiol Biomarkers Prev.  1998; 7 (2): 91-6
• Helicobacter pylori. Parsonnet J,  Infect Dis Clin North Am.  1998; 12 (1): 185-97
• Gastrin and colorectal cancer: a prospective study. Thorburn CM,  Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J.  Gastroenterology.  1998; 115 (2): 275-80
• Helicobacter pylori: the size of the problem. Parsonnet J,  Gut.  1998; 43 Suppl 1 S6-9
• Advances in the prevention and management of traveler's diarrhea. Passaro DJ,  Parsonnet J.  Curr Clin Top Infect Dis.  1998; 18 217-36
• Should we treat H. pylori infection to prevent gastric cancer? Parsonnet J,  Harris RA, Hack HM, Owens DK.  Gastroenterology.  1997; 112 (3): 1044-5
• Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Parsonnet J,  Friedman GD, Orentreich N, Vogelman H.  Gut.  1997; 40 (3): 297-301
• Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. Parsonnet J,  Replogle M, Yang S, Hiatt R.  J Infect Dis.  1997; 175 (5): 1240-2
• Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection. Witherell HL,  Hansen S, Jellum E, Orentreich N, Vogelman JH, Parsonnet J.  J Infect Dis.  1997; 176 (6): 1641-4
• Molecular mechanisms for inflammation-promoted pathogenesis of cancer--The Sixteenth International Symposium of the Sapporo Cancer Seminar. Parsonnet J,  Cancer Res.  1997; 57 (16): 3620-4
• Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. Smith K,  Parsonnet J.  N Engl J Med.  1997; 336 (8): 587; author reply 588
• Urinary phytoestrogen levels in young women from a multiethnic population. Horn-Ross PL,  Barnes S, Kirk M, Coward L, Parsonnet J, Hiatt RA.  Cancer Epidemiol Biomarkers Prev.  1997; 6 (5): 339-45
• Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Parsonnet J,  Harris RA, Hack HM, Owens DK.  Lancet.  1996; 348 (9021): 150-4
• Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan. Replogle ML,  Kasumi W, Ishikawa KB, Yang SF, Juji T, Miki K, Kabat GC, Parsonnet J.  Int J Epidemiol.  1996; 25 (1): 210-4
• Epidemiology of gastric non-Hodgkin's lymphoma patients: parallels with Helicobacter pylori. Thorburn C,  Rodriguez L, Parsonnet J.  Helicobacter.  1996; 1 (2): 75-8
• Helicobacter pylori in the stomach--a paradox unmasked. Parsonnet J,  N Engl J Med.  1996; 335 (4): 278-80
• Principles of screening and surveillance. Parsonnet J,  Axon AT.  Am J Gastroenterol.  1996; 91 (5): 847-9
• Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Replogle ML,  Glaser SL, Hiatt RA, Parsonnet J.  Am J Epidemiol.  1995; 142 (8): 856-63
• Bacterial infection as a cause of cancer. Parsonnet J,  Environ Health Perspect.  1995; 103 Suppl 8 263-8
• Flagellar serotypes of Salmonella typhi in Indonesia: relationships among motility, invasiveness, and clinical illness. Grossman DA,  Witham ND, Burr DH, Lesmana M, Rubin FA, Schoolnik GK, Parsonnet J.  J Infect Dis.  1995; 171 (1): 212-6
• The incidence of Helicobacter pylori infection. Parsonnet J,  Aliment Pharmacol Ther.  1995; 9 Suppl 2 45-51
• The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. Small PM,  Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK.  N Engl J Med.  1994; 330 (24): 1703-9
• H pylori and gastric cancer. Forman D,  Webb P, Parsonnet J.  Lancet.  1994; 343 (8891): 243-4
• Gastric adenocarcinoma and Helicobacter pylori infection. Parsonnet J,  West J Med.  1994; 161 (1): 60
• Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. Blaser MJ,  Parsonnet J.  J Clin Invest.  1994; 94 (1): 4-8
• Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Parsonnet J,  Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD.  Cancer Epidemiol Biomarkers Prev.  1993 Sep-Oct; 2 (5): 461-6
• Paraquat poisoning in southern Mexico: a report of 25 cases. Tinoco R,  Tinoco R, Parsonnet J, Halperin D.  Arch Environ Health.  1993 Mar-Apr; 48 (2): 78-80
• The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Guarner J,  Mohar A, Parsonnet J, Halperin D.  Cancer.  1993; 71 (2): 297-301
• Chronic idiopathic diarrhea. Mintz ED,  Parsonnet J, Osterholm MT.  N Engl J Med.  1993; 328 (23): 1713-4
• Another case of polymyositis after ciguatera toxin exposure. Stommel EW,  Jenkyn LR, Parsonnet J.  Arch Neurol.  1993; 50 (6): 571
• Helicobacter pylori and gastric cancer. Parsonnet J,  Gastroenterol Clin North Am.  1993; 22 (1): 89-104
• Hemolytic uremic syndrome: clinical picture and bacterial connection. Parsonnet J,  Griffin PM.  Curr Clin Top Infect Dis.  1993; 13 172-87
• Azathioprine hypersensitivity mimicking sepsis in a patient with Crohn's disease. Wilson BE,  Parsonnet J.  Clin Infect Dis.  1993; 17 (5): 940-1
• Salt intake and stomach cancer: some contrary evidence. Friedman GD,  Parsonnet J.  Cancer Epidemiol Biomarkers Prev.  1992 Nov-Dec; 1 (7): 607-8
• Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Parsonnet J,  Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV.  Gastroenterology.  1992; 102 (1): 41-6
• Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. Parsonnet J,  Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y.  J Natl Cancer Inst.  1991; 83 (9): 640-3
• Polymyositis after ciguatera toxin exposure. Stommel EW,  Parsonnet J, Jenkyn LR.  Arch Neurol.  1991; 48 (8): 874-7
• Multifocal colitis associated with an epidemic of chronic diarrhea. Janda RC,  Conklin JL, Mitros FA, Parsonnet J.  Gastroenterology.  1991; 100 (2): 458-64
• Molecular epidemiologic techniques in analysis of epidemic and endemic Shigella dysenteriae type 1 strains. Strockbine NA,  Parsonnet J, Greene K, Kiehlbauch JA, Wachsmuth IK.  J Infect Dis.  1991; 163 (2): 406-9
• Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Strauss RM,  Wang TC, Kelsey PB, Compton CC, Ferraro MJ, Perez-Perez G, Parsonnet J, Blaser MJ.  Am J Med.  1990; 89 (4): 464-9
• Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988. Parsonnet J,  Greene KD, Gerber AR, Tauxe RV, Vallejo Aguilar OJ, Blake PA.  Lancet.  1989; 2 (8662): 543-5
• Chronic diarrhea associated with drinking untreated water. Parsonnet J,  Trock SC, Bopp CA, Wood CJ, Addiss DG, Alai F, Gorelkin L, Hargrett-Bean N, Gunn RA, Tauxe RV.  Ann Intern Med.  1989; 110 (12): 985-91
• Trichosporon beigelii peritonitis. Parsonnet J,  South Med J.  1989; 82 (8): 1062-3
• International travel and the child younger than two years: I. Recommendations for immunization. Preblud SR,  Tsai TF, Brink EW, Nahlen BL, Parsonnet J.  Pediatr Infect Dis J.  1989; 8 (7): 416-25
• International travel and the child younger than two years: II. Recommendations for prevention of travelers' diarrhea and malaria chemoprophylaxis. Nahlen BL,  Parsonnet J, Preblud SR, Tsai TF, Brink EW.  Pediatr Infect Dis J.  1989; 8 (11): 735-9
• Simple microbiologic detection of Campylobacter pylori. Parsonnet J,  Welch K, Compton C, Strauss R, Wang T, Kelsey P, Ferraro MJ.  J Clin Microbiol.  1988; 26 (5): 948-9